British PM Boris Johnson received his first dose of AstraZeneca's Covid vaccine on Friday. The 56-year-old UK PM took to Twitter and shared a video urging the public to do the same. Johnson received the jab at Gassiot House Outpatient Centre in London's St Thomas' Hospital. Last year, Johnson was diagnosed with Covid and was admitted to the hospital for treatment. Johnson had spent a week at St Thomas' Hospital including three days in intensive care. AstraZeneca's jab, developed with Oxford, provides the bulk of Britain's inoculation campaign. A large portion of its supply has also been produced by the Serum Institute of India.
Credit: HT Digital Content Duration: 02:03Published
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now. This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.
Prime Minister Narendra Modi held a meeting with oxygen manufacturers in the country via video-conferencing on April 23. The meeting was attended by Reliance, Tata Steels, SAIL, etc. Requirement of oxygen has soared in hospitals in the country due to COVID situation.
Under-30s in the UK will be offered Pfizer or Moderna vaccines rather than the Oxford/AstraZeneca vaccine due to concerns over a very rare risk of blood clots. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said there were still huge benefits of the vaccine in preventing Covid-19, and has not concluded that the vaccine causes rare clots, although it says the link is getting firmer. Report by Patelr. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, making it the country's first approved shot for general public use, as it braces..